Everence Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Everence Capital Management's RVMD Position: Q3 2026 in Review
Everence Capital Management reduced its Revolution Medicines (RVMD) stake by 8.4% in Q3 2026, selling an estimated $103K and leaving 5,634 shares worth $1.16M. The position accounts for 0.06% of the portfolio, ranked #232.
Everence Capital Management first reported a position in RVMD in Q4 2024 and has held it in 6 quarters since. 749 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Everence Capital Management held 5,634 shares of Revolution Medicines worth $1.16M as of Q3 2026.
- Everence Capital Management sold 518 Revolution Medicines shares in Q3 2026, an estimated $103K.
- Revolution Medicines made up 0.06% of Everence Capital Management's portfolio in Q3 2026, its #232 holding.
- Everence Capital Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 6 quarters since.
- 749 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.